Search research articles
Contact Us
Filters
Showing results (121-130 of 131) with videos related to
Page
of 14
Sort By:
Blood Advances
|
January 4, 2018
EPHB4 is a therapeutic target in AML and promotes leukemia cell survival via AKT
Akil A Merchant, Aparna Jorapur, Amy McManus, et al.
Plos One
|
August 18, 2017
EphB4/EphrinB2 therapeutics in Rhabdomyosarcoma
Matthew E Randolph, Megan M Cleary, Zia Bajwa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 20, 2013
Monoclonal antibody against cell surface GRP78 as a novel agent in suppressing PI3K/AKT signaling, tumor growth, and metastasis
Ren Liu, Xiuqing Li, Wenming Gao, et al.
Cancer Research
|
April 16, 2009
Preferential induction of EphB4 over EphB2 and its implication in colorectal cancer progression
S Ram Kumar, Jeffrey S Scehnet, Eric J Ley, et al.
British Journal of Cancer
|
July 17, 2015
Axl receptor tyrosine kinase is a potential therapeutic target in renal cell carcinoma
H Yu, R Liu, B Ma, et al.
Cancers
|
July 24, 2021
Tyrosine Phosphoproteomics of Patient-Derived Xenografts Reveals Ephrin Type-B Receptor 4 Tyrosine Kinase as a Therapeutic Target in Pancreatic Cancer
Santosh Renuse, Vijay S Madamsetty, Dong-Gi Mun, et al.
Cancer Research
|
June 3, 2005
EphB4 expression and biological significance in prostate cancer
Guangbin Xia, S Ram Kumar, Rizwan Masood, et al.
Plos One
|
July 12, 2013
The EphB4 receptor tyrosine kinase promotes lung cancer growth: a potential novel therapeutic target
Benjamin D Ferguson, Ren Liu, Cleo E Rolle, et al.
Molecular Cancer Therapeutics
|
August 5, 2010
Converging evidence for efficacy from parallel EphB4-targeted approaches in ovarian carcinoma
Whitney A Spannuth, Lingegowda S Mangala, Rebecca L Stone, et al.
Biorxiv : the Preprint Server for Biology
|
August 2, 2024
Long shared haplotypes identify the Southern Urals as a primary source for the 10th century Hungarians
Balázs Gyuris, Leonid Vyazov, Attila Türk, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 131) with videos related to
Sort By:
Page
of 14
Blood Advances
|
January 4, 2018
EPHB4 is a therapeutic target in AML and promotes leukemia cell survival via AKT
Akil A Merchant, Aparna Jorapur, Amy McManus, et al.
Plos One
|
August 18, 2017
EphB4/EphrinB2 therapeutics in Rhabdomyosarcoma
Matthew E Randolph, Megan M Cleary, Zia Bajwa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 20, 2013
Monoclonal antibody against cell surface GRP78 as a novel agent in suppressing PI3K/AKT signaling, tumor growth, and metastasis
Ren Liu, Xiuqing Li, Wenming Gao, et al.
Cancer Research
|
April 16, 2009
Preferential induction of EphB4 over EphB2 and its implication in colorectal cancer progression
S Ram Kumar, Jeffrey S Scehnet, Eric J Ley, et al.
British Journal of Cancer
|
July 17, 2015
Axl receptor tyrosine kinase is a potential therapeutic target in renal cell carcinoma
H Yu, R Liu, B Ma, et al.
Cancers
|
July 24, 2021
Tyrosine Phosphoproteomics of Patient-Derived Xenografts Reveals Ephrin Type-B Receptor 4 Tyrosine Kinase as a Therapeutic Target in Pancreatic Cancer
Santosh Renuse, Vijay S Madamsetty, Dong-Gi Mun, et al.
Cancer Research
|
June 3, 2005
EphB4 expression and biological significance in prostate cancer
Guangbin Xia, S Ram Kumar, Rizwan Masood, et al.
Plos One
|
July 12, 2013
The EphB4 receptor tyrosine kinase promotes lung cancer growth: a potential novel therapeutic target
Benjamin D Ferguson, Ren Liu, Cleo E Rolle, et al.
Molecular Cancer Therapeutics
|
August 5, 2010
Converging evidence for efficacy from parallel EphB4-targeted approaches in ovarian carcinoma
Whitney A Spannuth, Lingegowda S Mangala, Rebecca L Stone, et al.
Biorxiv : the Preprint Server for Biology
|
August 2, 2024
Long shared haplotypes identify the Southern Urals as a primary source for the 10th century Hungarians
Balázs Gyuris, Leonid Vyazov, Attila Türk, et al.
Page
of 14